Hedge Fund Database

BIRCHVIEW CAPITAL, LP

Adviser information for BIRCHVIEW CAPITAL, LP last updated from Form ADV on August 21st, 2023. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 5
Investment Advisory/Research 2
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 16 $210.5M
Non-Discretionary 0 $0
Total 16 $210.5M

Clients

Type Number RAUM
Individuals <5 $812,041
HNW Individuals <5 $115.9M
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 12 $93.8M
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 0

Services

Advisory Services Portfolio management for individuals and/or small businessesPortfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-79710
SEC ERA File Number 801-79710
SEC CIK Numbers 1618205
SEC CRD Numbers 170534
Legal Entity Identifier None

Principal Office

688 PINE STREET
2ND FLOOR
BURLINGTON
VT
United States
Monday - Friday, 8:30 AM - 5:30 PM
Tel: 802-923-3080, Fax: None

Chief Compliance Officer

JOHN TROTTIER
688 PINE STREET
2ND FLOOR
BURLINGTON
VT
United States
Tel: 802-923-3826
(Full email address available in API data)

Regulatory Contact

KARL COLE-FRIEMAN
COMPLIANCE COUNSEL
C/O COLE-FRIEMAN & MALLON LLP
201 CALIFORNIA STREET, STE 350
SAN FRANCISCO
CA
United States
Tel: 415-762-2841
Fax: 415-493-0154
(Full email address available in API data)

Industry Affiliates

BIRCHVIEW PARTNERS, LLC Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
BIRCHVIEW CAPITAL VF III, LLC Private Equity Fund $4.6M $0.0M 9
BIRCHVIEW FUND LLC Hedge Fund $62.1M $1.0M 39
ED BC HOLDINGS 3, LLC Private Equity Fund $0.0M $0.0M 8
ED BC HOLDINGS LLC Private Equity Fund $0.0M $0.0M 7
MONTERIS BC HOLDINGS 2, LLC Private Equity Fund $0.0M $0.0M 18
MONTERIS BC HOLDINGS 3, LLC Private Equity Fund $0.0M $0.0M 18
MONTERIS BC HOLDINGS 4 LLC Private Equity Fund $1.0M $0.0M 13
MONTERIS BC HOLDINGS 5 LLC Private Equity Fund $19.0M $0.0M 19
MONTERIS BC HOLDINGS 6 LLC Private Equity Fund $4.5M $0.0M 11
MONTERIS BC HOLDINGS 7 LLC Private Equity Fund $2.5M $0.0M 14
MONTERIS BC HOLDINGS, LLC Private Equity Fund $0.0M $0.0M 20
MONTERIS BC NOTE LLC Private Equity Fund $0.0M $0.0M 18

Control Persons

Name Type Entity Title Since Ownership
STROBECK, MATTHEW, WILLIAM Individual – CHIEF INVESTMENT OFFICER AND MANAGING PARTNER 02/2014 > 75%
SMALL, BENJAMIN, GRANT Individual – CHIEF OPERATING OFFICER 02/2014 < 5%
BIRCHVIEW CAPITAL GP, LLC Domestic Entity – GENERAL PARTNER 02/2014 < 5%
STROBECK, MATTHEW, WILLIAM Individual BIRCHVIEW CAPITAL GP, LLC MANAGING MEMBER 02/2014 > 75%
TROTTIER, JOHN, BOARDMAN Individual – CHIEF FINANCIAL OFFICER 11/2022 < 5%
TROTTIER, JOHN, BOARDMAN Individual – CHIEF COMPLIANCE OFFICER 08/2023 < 5%

No. Employees, Historic

10502019202020212022202320243 on 5/6/20193 on 3/30/20203 on 6/12/20203 on 6/29/20203 on 3/30/20214 on 9/29/20214 on 3/17/20227 on 3/22/20237 on 4/25/20237 on 5/18/20237 on 6/14/20235 on 8/21/2023

RAUM, Historic

300M150M0201920202021202220232024155011235 on 5/6/2019219005658 on 3/30/2020192622328 on 6/12/2020192622328 on 6/29/2020250166198 on 3/30/2021246162895 on 9/29/2021231455662 on 3/17/2022210506714 on 3/22/2023210506714 on 4/25/2023210506714 on 5/18/2023210506714 on 6/14/2023210506714 on 8/21/2023

No. Clients, Historic

201002019202020212022202320246 on 5/6/20197 on 3/30/20208 on 6/12/20208 on 6/29/20209 on 3/30/202110 on 9/29/202110 on 3/17/202212 on 3/22/202312 on 4/25/202312 on 5/18/202312 on 6/14/202312 on 8/21/2023

Holdings

From latest 13F, filed August 13th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
10X GENOMICS INC CL A COM 584K 30K –
2SEVENTY BIO INC COM 69K 18K –
ACADIA PHARMACEUTICALS INC COM 4M 250K –
ACCELERATE DIAGNOSTICS INC COM 381K 325K –
ALKERMES PLC SHS 1M 50K –
AMICUS THERAPEUTICS INC COM 278K 28K –
APELLIS PHARMACEUTICALS INC COM 537K 14K –
ARVINAS INC COM 399K 15K –
ALPHATEC HOLDINGS INC COM 920K 88K –
AXOGEN INC COM 1M 197K –
AXSOME THERAPEUTICS INC COM 322K 4K –
BIOCRYST PHARMACEUTICALS INC COM 247K 40K –
BIODESIX INC COM 8M 5M –
BIODESIX INC COM RST COM 228K 154K –
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD COM 256K 7K –
BLUEBIRD BIO INC COM 306K 311K –
BRISTOL-MYERS SQUIBB CO COM 29M 688K –
CABALETTA BIO INC COM 75K 10K –
CASTLE BIOSCIENCES INC COM 740K 34K –
CERO THERAPEUTICS HOLDINGS INC CLASS A COM 4K 13K –
COHERUS BIOSCIENCES INC COM 467K 270K –
CORCEPT THERAPEUTICS INC COM 2M 74K –
CULLINAN ONCOLOGY INC COM 349K 20K –
CYTOKINETICS INC COM 542K 10K –
DOCGO INC COM 1M 460K –
ELUTIA INC COM 8M 2M –
EQUITRANS MIDSTREAM CORPORATIO COM 2M 133K –
EXXON MOBIL CORP COM 673K 6K –
FOGHORN THERAPEUTICS INC COM 2M 321K –
G1 THERAPEUTICS INC COM 182K 80K –
GOSSAMER BIO INC COM 124K 138K –
HALOZYME THERAPEUTICS INC COM 524K 10K –
HARROW HEALTH INC COM 3M 150K –
INFLARX NV COM 87K 50K –
INHIBRX BIOSCIENCES INC COM 171K 12K –
KALVISTA PHARMACEUTICALS INC COM 542K 46K –
KARYOPHARM THERAPEUTICS INC COM 408K 470K –
KEROS THERAPEUTICS INC COM 320K 7K –
KINIKSA PHARMACEUTICALS LTD COM 560K 30K –
LIQUIDIA CORPORATION COM 120K 10K –
MASIMO CORP COM 2M 15K –
NEUROCRINE BIOSCIENCES INC COM 6M 42K –
NOVOCURE LTD ORD SHS 343K 20K –
OUTSET MEDICAL INC COM 39K 10K –
OVINTIV INC COM 3M 74K –
PHREESIA INC COM 2M 115K –
PROGYNY INC COM 629K 22K –
PROTAGONIST THERAPEUTICS INC COM 2M 48K –
PROTHENA CORP PLC SHS 4M 204K –
QUIDELORTHO CORP COM 2M 68K –
SAREPTA THERAPEUTICS INC COM 395K 3K –
SILK ROAD MEDICAL INC COM 4M 158K –
SPRINGWORKS THERAPEUTICS INC COM 377K 10K –
STOKE THERAPEUTICS INC COM 3M 210K –
TRAVERE THERAPEUTICS INC COM 1M 122K –
UNITED THERAPEUTICS CORP COM 3M 10K –
VENTYX BIOSCIENCES INC COM 67K 29K –
WAVE LIFE SCIENCES LTD SHS 200K 40K –
XENCOR INC COM 233K 12K –
XENON PHARMACEUTICALS INC COM 390K 10K –
ZENTALIS PHARMACEUTICALS INC COM 65K 16K –